Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FGRXZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,669
Award facts
- Contract value 100% obligated
- $2,669.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Zepbound 15 mg/0.5 ml pen injectable medication with a ceiling value of $2,669.03. This is a firm fixed price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for ultimate completion by October 23, 2025, and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support defense healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. This delivery order for Zepbound, a diabetes treatment medication, exemplifies the company's role as a critical vendor fulfilling specialized pharmaceutical requirements for the Defense Health Agency and other federal healthcare systems through competitively awarded contracts with firm fixed pricing structures.
Quick answers
Who was awarded contract SPE2DB26FGRXZ?
SPE2DB26FGRXZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FGRXZ worth?
The government has obligated $2,669 on SPE2DB26FGRXZ.
Is contract SPE2DB26FGRXZ an order under another contract?
Yes. SPE2DB26FGRXZ is a delivery order under SPE2DB24D2215, an indefinite delivery contract.
Was contract SPE2DB26FGRXZ competed?
The extent of competition for SPE2DB26FGRXZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award